Zivo Bioscience, Inc. (ZIVO)
6.50
-0.01
(-0.21%)
USD |
OTCM |
Oct 16, 16:00
Zivo Bioscience Debt to Equity Ratio : -0.1684 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1684 |
| March 31, 2026 | -0.2254 |
| December 31, 2025 | -0.17 |
| September 30, 2025 | -0.2494 |
| June 30, 2025 | -0.3066 |
| March 31, 2025 | -0.6026 |
| December 31, 2024 | -0.4941 |
| September 30, 2024 | -0.181 |
| June 30, 2024 | -0.252 |
| March 31, 2024 | -0.3434 |
| December 31, 2023 | -0.157 |
| September 30, 2023 | -1.373 |
| June 30, 2023 | -0.48 |
| March 31, 2023 | -0.5514 |
| December 31, 2022 | -42.00 |
| September 30, 2022 | 0.3965 |
| June 30, 2022 | 0.2766 |
| March 31, 2022 | 0.2203 |
| December 31, 2021 | 0.0422 |
| September 30, 2021 | 0.034 |
| June 30, 2021 | 0.0626 |
| March 31, 2021 | -0.4817 |
| December 31, 2020 | -0.4735 |
| September 30, 2020 | -0.4879 |
| June 30, 2020 | -0.5357 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5713 |
| December 31, 2019 | -0.6332 |
| September 30, 2019 | -0.6842 |
| June 30, 2019 | -0.6843 |
| March 31, 2019 | -0.7981 |
| December 31, 2018 | -0.8342 |
| September 30, 2018 | -0.8486 |
| June 30, 2018 | -0.8732 |
| March 31, 2018 | -0.9738 |
| December 31, 2017 | -0.8854 |
| September 30, 2017 | -0.979 |
| June 30, 2017 | -0.9166 |
| March 31, 2017 | -0.9744 |
| December 31, 2016 | -0.7803 |
| September 30, 2016 | -0.7712 |
| June 30, 2016 | -0.6739 |
| March 31, 2016 | -0.68 |
| December 31, 2015 | -0.6487 |
| September 30, 2015 | -0.6601 |
| June 30, 2015 | -0.6225 |
| March 31, 2015 | -0.6164 |
| December 31, 2014 | -0.6069 |
| September 30, 2014 | -1.004 |
| June 30, 2014 | -0.5717 |
| March 31, 2014 | -0.5261 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| PMGC Holdings, Inc. | 0.8507 |
| Shonghoya Intl Group, Inc. | 0.00 |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | 0.00 |
| CCA Industries, Inc. | 0.0763 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.4435M |
| Total Liabilities (Quarterly) | 3.826M |
| Shareholders Equity (Quarterly) | -3.382M |
| Current Ratio | 0.1023 |
| Net Debt Paydown Yield | 0.48% |